White Paper

Developing Advanced Therapies: Considerations For Internal Versus External Manufacturing

Vial drug development.jpg

Due to their complexity and cost, developers of cell and gene therapies face unique manufacturing hurdles. Determining the right approach to manufacturing is crucial when bringing these advanced therapeutics from clinical to commercialization. Recently, Precision for Medicine co- sponsored a webinar with Informa Pharma Intelligence, bringing together high-profile leaders in the cell and gene therapy space to discuss key considerations for cell and gene therapies. The combined expertise of these four panelists in their respective fields of investment management; manufacturing and technical operations; global pricing; and commercialization, advocacy, and legislation provided a distinctive perspective on how to approach manufacturing and other roadblocks at every stage of development.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: